Development of rosuvastatin flexible lipid-based nanoparticles: promising nanocarriers for improving intestinal cells cytotoxicity

被引：0
|
作者：
Tarek A. Ahmed
机构：
[1] King Abdulaziz University,Department of Pharmaceutics, Faculty of Pharmacy
[2] Al-Azhar University,Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy
来源：
BMC Pharmacology and Toxicology | / 21卷
关键词：
Rosuvastatin; Optimization; Chitosomes; Liposomes; cell viability; Cytotoxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Lipid-Based Nanoparticles for Drug/Gene Delivery: An Overview of the Production Techniques and Difficulties Encountered in Their Industrial Development
    Mehta, Meenu
    Bui, Thuy Anh
    Yang, Xinpu
    Aksoy, Yagiz
    Goldys, Ewa M.
    Deng, Wei
    ACS MATERIALS AU, 2023, 3 (06): : 600 - 619
  • [32] Synthetic bioreducible lipid-based nanoparticles for miRNA delivery to mesenchymal stem cells to induce neuronal differentiation
    Takeda, Yuji S.
    Wang, Ming
    Deng, Pu
    Xu, Qiaobing
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2016, 1 (02) : 160 - 167
  • [33] DEVELOPING LIPID-BASED NANOPARTICLES FOR SYSTEMIC DELIVERY OF MESENCHYMAL STEM CELLS SECRETOME IN PARKINSON'S DISEASE
    Barata-Antunes, Sandra
    Sousa, Rui A.
    Silva, Bruno F. B.
    Salgado, Antonio J.
    TISSUE ENGINEERING PART A, 2022, 28 : S179 - S180
  • [34] Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv
    Loomis, Kristin
    Smith, Brandon
    Feng, Yang
    Garg, Himanshu
    Yavlovich, Amichai
    Campbell-Massa, Ryan
    Dimitrov, Dimiter S.
    Blumenthal, Robert
    Xiao, Xiaodong
    Puri, Anu
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2010, 88 (02) : 238 - 249
  • [35] Development of a Combined Lipid-Based Nanoparticle Formulation for Enhanced siRNA Delivery to Vascular Endothelial Cells
    He, Yutong
    Bi, Dongdong
    Plantinga, Josee A.
    Molema, Grietje
    Bussmann, Jeroen
    Kamps, Jan A. A. M.
    PHARMACEUTICS, 2022, 14 (10)
  • [36] A novel lipid-based drug carrier targeted to the crucial cells in the development of liver fibrosis.
    Adrian, JE
    Meijer, DKF
    Scherphof, GL
    Poelstra, K
    Kamps, JAAM
    HEPATOLOGY, 2004, 40 (04) : 545A - 545A
  • [37] Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties
    Rodrigues, Bruna dos Santos
    Lakkadwala, Sushant
    Kanekiyo, Takahisa
    Singh, Jagdish
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2019, 14 : 6497 - 6517
  • [38] Development of New Natural Lipid-Based Nanoparticles Loaded with Aluminum-Phthalocyanine for Photodynamic Therapy against Melanoma
    Mello, Victor Carlos
    Araujo, Victor Hugo Sousa
    Rodrigues de Paiva, Karen Letycia
    Simoes, Marina Mesquita
    Marques, Dafne Caroline
    da Silva Costa, Nelice Roberta
    de Souza, Isadora Florencio
    da Silva, Patricia Bento
    Santos, Igor
    Almeida, Raquel
    Magalhaes, Kelly Grace
    da Silva, Sebastiao William
    Santos, Alexandre Silva
    Veiga-Souza, Fabiane
    Narcizo Souza, Paulo Eduardo
    Raddichi, Marina Arantes
    Figueiro Longo, Joao Paulo
    Cavalcante de Araujo, Jennifer Thayanne
    Muehlmann, Luis Alexandre
    Chorilli, Marlus
    Bao, Sonia Nair
    NANOMATERIALS, 2022, 12 (20)
  • [39] Cell-Specific Promoters Enable Lipid-Based Nanoparticles to Deliver Genes to Specific Cells of the Retina In Vivo
    Wang, Yuhong
    Rajala, Ammaji
    Cao, Binrui
    Ranjo-Bishop, Michelle
    Agbaga, Martin-Paul
    Mao, Chuanbin
    Rajala, Raju V. S.
    THERANOSTICS, 2016, 6 (10): : 1514 - 1527
  • [40] Development of a high-throughput in vitro intestinal lipolysis model for rapid screening of lipid-based drug delivery systems
    Mosgaard, Mette D.
    Sassene, Philip
    Mu, Huiling
    Rades, Thomas
    Muellertz, Anette
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 94 : 493 - 500
12345